Atypical antipsychotics and neuroleptic malignant syndrome.
Velamoor
V R
VR
D014150:Antipsychotic Agents / Q000009:adverse effects* / Q000627:therapeutic use; D002389:Catatonia / Q000139:chemically induced* / Q000175:diagnosis; D003024:Clozapine / Q000009:adverse effects* / Q000627:therapeutic use; D006801:Humans; D009459:Neuroleptic Malignant Syndrome / Q000175:diagnosis / Q000209:etiology*; D017448:Receptors, Dopamine D2 / Q000187:drug effects; D012307:Risk Factors
D014150:Antipsychotic Agents; D017448:Receptors, Dopamine D2; D003024:Clozapine